Prenatal diagnosis of intrauterine rubella.

Infection

Published: September 1987

The results of prenatal diagnosis of fetal rubella infection by specific IgM antibody detection in fetal infection by specific IgM antibody detection in fetal blood obtained in the 21st to 23rd weeks of pregnancy of women with different types of rubella problems during pregnancy (categorised in four groups) showed that in 28 of 31 cases the diagnosis apparently assisted in the correct management of the pregnancy. However, in two cases with negative IgM findings in the fetal blood, children with rubella embryopathy were born, and in one case with positive IgM antibody findings, the child was infected but healthy. From this experience we recommend that in all cases of symptomatic rubella infection in the first 12 weeks, termination of pregnancy should be considered without prenatal diagnosis. Prenatal diagnosis, if considered at all, should be limited to "symptomless" acute rubella infection and reinfection in the first 12 weeks and to symptomatic rubella infection in the 12th to 17th weeks of pregnancy.

Download full-text PDF

Source
http://dx.doi.org/10.1007/BF01646038DOI Listing

Publication Analysis

Top Keywords

prenatal diagnosis
16
rubella infection
16
igm antibody
12
infection specific
8
specific igm
8
antibody detection
8
detection fetal
8
fetal blood
8
weeks pregnancy
8
symptomatic rubella
8

Similar Publications

Objective: The first objective is to develop a nuchal thickness reference chart. The second objective is to compare rule-based algorithms and machine learning models in predicting small-for-gestational-age infants.

Method: This retrospective study involved singleton pregnancies at University Malaya Medical Centre, Malaysia, developed a nuchal thickness chart and evaluated its predictive value for small-for-gestational-age using Malaysian and Singapore cohorts.

View Article and Find Full Text PDF

Determining the differential diagnosis of small scalp cysts identified on a fetus is difficult. In particular, many physicians have difficulty differentiating small meningoceles from small scalp cysts during the prenatal period. Volume contrast imaging increases contrast between tissues, thereby allowing an enhanced view of target structures.

View Article and Find Full Text PDF

Unraveling the genetic mysteries of spinal muscular atrophy in Chinese families.

Orphanet J Rare Dis

January 2025

The Genetics and Prenatal Diagnosis Center, The Department of Obstetrics and Gynecology, The First Affiliated Hospital of Zhengzhou University, Jianshe Rd, Erqi District, Zhengzhou, 450052, Henan, China.

Objective: Spinal muscular atrophy (SMA) is a motor neuron disorder encompassing 5q and non-5q forms, causing muscle weakness and atrophy due to spinal cord cell degeneration. Understanding its genetic basis is crucial for genetic counseling and personalized treatment options.

Methods: This study retrospectively analyzed families of patients suspected of SMA at our institution from February 2006 to March 2024.

View Article and Find Full Text PDF

Background: Today, the screening of fetal abnormalities during pregnancy is used as one of the components of the prenatal care worldwide, and many abnormalities are detected by ultrasound during pregnancy. On the other hand, the possibility of an abnormality in the fetus causes worry and anxiety in pregnant women. Therefore, the present study was conducted with the aim of determining the relationship between worry and anxiety with the general health status of pregnant women at risk of diagnosing fetal abnormalities.

View Article and Find Full Text PDF

Congenital muscular dystrophies and myopathies: the leading cause of genetic muscular disorders in eleven Chinese families.

BMC Musculoskelet Disord

January 2025

Medical Genetic Diagnosis and Therapy Center, Fujian Maternity and Child Health Hospital, College of Clinical Medicine for Obstetrics and Gynecology and Pediatrics, Fujian Medical University, 18 Daoshan Road, Fuzhou, 350001, China.

Background: Congenital muscular dystrophies (CMDs) and myopathies (CMYOs) are a clinically and genetically heterogeneous group of neuromuscular disorders that share common features, such as muscle weakness, hypotonia, characteristic changes on muscle biopsy and motor retardation. In this study, we recruited eleven families with early-onset neuromuscular disorders in China, aimed to clarify the underlying genetic etiology.

Methods: Essential clinical tests, such as biomedical examination, electromyography and muscle biopsy, were applied to evaluate patient phenotypes.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!